Anti-SARS-CoV-2 RBD Neutralizing Antibody Solution H (1X)

Anti-SARS-CoV-2 RBD Neutralizing Antibody Solution H (1X)

Product No.: S125

- -
- -
Product No.S125
Product Type
Reagents for Assay Development
Alternate Names
SARS-CoV-2 Spike RBD Antibody, Receptor-Binding Domain, Spike

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Expression Host
HEK-293 Cells
Endotoxin Level
< 1.0 EU/mg as determined by the LAL method
≥95% monomer by analytical SEC
This antibody solution is formulated in a protein solution of 0.01 M phosphate buffered saline, pH 7.2, containing ProClin-300 as a preservative.
Product Preparation
Recombinant antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling
This Anti-SARS-CoV-2 RBD Neutralizing Antibody Solution H (1X) is stable when stored at 2-8°C for up to 6 months.
Country of Origin
Standard Overnight on Blue Ice.
Applications and Recommended Usage?
Quality Tested by Leinco
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
This SARS-CoV-2 neutralizing antibody solution is prediluted in a stabilized buffer at a concentration that will neutralize SARS-CoV-2 RBD wild-type and variants, UK, South Africa, and Brazil.

Antigen Details

Research Area
Seasonal and Respiratory Infections
Indirect Elisa Protocol
Products are for research use only. Not for use in diagnostic or therapeutic procedures.